​

Precision BioSciences (DTIL) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChart

DTIL Stock Forecast

Precision BioSciences (DTIL) stock forecast, based on 3 Wall Street analysts, predicts a 12-month average price target of $15.50, with a high of $30.00 and a low of $1.00. This represents a 215.68% increase from the last price of $4.91.

- $6 $12 $18 $24 $30 High: $30 Avg: $15.5 Low: $1 Last Closed Price: $4.91

DTIL Stock Rating

Precision BioSciences stock's rating consensus is Buy, based on 3 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 3 Buy (100.00%), 0 Hold (0.00%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 3 0 3 Strong Sell Sell Hold Buy Strong Buy

DTIL Forecast vs Benchmarks

TypeNameUpside
StockPrecision BioSciences215.68%
SectorHealthcare Stocks 25.20%
IndustryBiotech Stocks 63.35%

Price Target Trends

1M3M12M
# Anlaysts--1
Avg Price Target--$30.00
Last Closing Price$4.91$4.91$4.91
Upside/Downside--511.00%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Jan, 25231--6
Dec, 24131--5
Nov, 24231--6
Oct, 24331--7
Sep, 24341--8
Latest Price Target by Analysts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Apr 01, 2024Justin ZelinBTIG$30.00$13.56121.24%511.00%
Nov 10, 2022Goldman Sachs$1.00$1.38-27.54%-79.63%
Latest Upgrade/Downgrade by Analysts
DateCompanyPrevious RatingNew RatingRating Change
Jan 10, 2025BMO CapitalMarket PerformOutperformupgrade
Nov 04, 2024BMO CapitalMarket PerformMarket Performhold
May 16, 2024GuggenheimUnderperformUnderperformhold
Apr 01, 2024BTIGBuyBuyhold
Jun 17, 2022BMO CapitalOutperforminitialise

Financial Forecast

EPS Forecast

$-80 $-63 $-46 $-29 $-12 $5 Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-2.09$-0.53$-1.40$-0.02-----
Avg Forecast$-65.49$-18.84$-35.73$-15.09$0.07$-7.02$-3.79$-3.22$-3.02
High Forecast$-75.64$-21.76$-46.44$-22.74$0.05$-10.58$-6.90$-5.50$-4.55
Low Forecast$-56.62$-16.29$-29.49$-10.60$0.10$-4.93$0.06$0.20$-2.12
Surprise %-96.81%-97.19%-96.08%-99.87%-----

Revenue Forecast

$0 $30M $60M $90M $120M $150M Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$24.29M$115.53M$25.10M$48.73M-----
Avg Forecast$21.26M$116.73M$21.58M$53.27M$72.30M$20.02M$31.73M$32.83M$35.53M
High Forecast$19.05M$104.56M$18.68M$41.07M$55.75M$15.44M$31.73M$32.83M$27.40M
Low Forecast$23.80M$130.64M$26.56M$74.03M$100.48M$27.83M$31.73M$32.83M$49.38M
Surprise %14.22%-1.02%16.29%-8.53%-----

Net Income Forecast

$-300M $-230M $-160M $-90M $-20M $50M Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-109.01M$-30.92M$-122.91M$-61.32M-----
Avg Forecast$-251.56M$-72.36M$-137.24M$-42.53M$286.40K$-29.80M$-13.14M$-10.18M$-11.60M
High Forecast$-290.55M$-83.58M$-178.41M$-87.34M$182.12K$-40.64M$-26.51M$-21.13M$-17.48M
Low Forecast$-217.49M$-62.56M$-113.27M$-40.71M$390.67K$-18.95M$230.49K$768.29K$-8.15M
Surprise %-56.67%-57.27%-10.45%44.19%-----

DTIL Forecast FAQ

Is Precision BioSciences stock a buy?

Precision BioSciences stock has a consensus rating of Buy, based on 3 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 3 Buy, 0 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that Precision BioSciences is a favorable investment for most analysts.

What is Precision BioSciences's price target?

Precision BioSciences's price target, set by 3 Wall Street analysts, averages $15.5 over the next 12 months. The price target range spans from $1 at the low end to $30 at the high end, suggesting a potential 215.68% change from the previous close price of $4.91.

How does Precision BioSciences stock forecast compare to the average forecast of its sector, industry, and investment themes?

Precision BioSciences stock forecast shows a 215.68% upside, outperforming the average forecast for the healthcare stocks sector (25.20%) and outperforming the biotech stocks industry (63.35%).

What is the breakdown of analyst ratings for Precision BioSciences over the past three months?

  • January 2025: 33.33% Strong Buy, 50.00% Buy, 16.67% Hold, 0% Sell, 0% Strong Sell.
  • December 2024: 20.00% Strong Buy, 60.00% Buy, 20.00% Hold, 0% Sell, 0% Strong Sell.
  • November 2024: 33.33% Strong Buy, 50.00% Buy, 16.67% Hold, 0% Sell, 0% Strong Sell.

What is Precision BioSciences’s EPS forecast?

Precision BioSciences's average annual EPS forecast for its fiscal year ending in December is 0.07 for 2024, a -450.00% decrease from the reported $-0.02 in 2023. The prediction for 2025 is $-7.02, $-3.79 for 2026, $-3.22 for 2027, and $-3.02 for 2028.

What is Precision BioSciences’s revenue forecast?

Precision BioSciences's average annual revenue forecast for its fiscal year ending in December is $72.3M for 2024, a 48.38% increase from the reported $48.73M in 2023. The forecast for 2025 is $20.02M, $31.73M for 2026, $32.83M for 2027, and $35.53M for 2028.

What is Precision BioSciences’s net income forecast?

For its fiscal year ending in December, Precision BioSciences's average annual net income forecast is $286.4K for 2024, reflecting a -100.47% decrease from the reported $-61.319M in 2023. The projection for 2025 is $-29.795M, $-13.138M for 2026, $-10.18M for 2027, and $-11.601M for 2028.